Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | tert-Butyldiphenylchlorosilane | HCID 94078 | — |
| Reactant | HCID 70170745 | HCID 70170745 | — |
| Product | HCID 10909025 | HCID 10909025 | — |
Reaction Steps
A mixture of (S)-N-[1-(7-hydroxynaphthalen-1-yl)-2-oxopyrrolidin-3-yl]-2-[1-(triphenylmethyl)-1H-imidazol-4-yl]acetamide, as described above in Step C, (6.50 g, 11.0 mmol), tert-butyldiphenylsilyl chloride (4.55 g, 16.6 mol), and imidazole (1.87 g, 27.5 mol) in dry, degassed DMF (100 mL) was stirred, under argon, at 50° C. for 18 hours. The solvent was removed under reduced pressure and the residue was partitioned between saturated aqueous NaHCO3 (75 mL) and CH2Cl2 (125 mL). The aqueous layer was extracted further with CH2Cl2 (125 mL) and the combined organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. The crude product was purified by flash column chromatography on silica, eluting with CH2Cl2—1% MeOH—0.1% NH4OH to yield the desired product as a pale solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06441017B1 |
|---|
| Source dataset | uspto-grants-2002_08 |
|---|
| ORD ID | ord-3c83d2aa5ee040fd996a8ea1feea37cc |
|---|
| Source note | uspto-grants-2002_08 |
|---|